Home » Analyst Articles – US

Morgan Stanley Reiterates Sell Rating for Tellurian (NASDAQ:TELL)

Morgan Stanley Reiterates Sell Rating for Tellurian (NASDAQ:TELL)

Tellurian (NASDAQ:TELL)‘s stock had its “sell” rating reiterated by stock analysts at Morgan Stanley in a report released on Sunday, AnalystRatings.com reports. Several other brokerages have also issued reports on... 
Argonaut Gold’s (ARNGF) “Buy” Rating Reiterated at BMO Capital Markets

Argonaut Gold’s (ARNGF) “Buy” Rating Reiterated at BMO Capital Markets

Argonaut Gold (OTCMKTS:ARNGF)‘s stock had its “buy” rating reaffirmed by equities research analysts at BMO Capital Markets in a research report issued on Sunday, AnalystRatings.com reports. They presently have a $3.00... 
Morphic (NASDAQ:MORF) Stock Rating Reaffirmed by BMO Capital Markets

Morphic (NASDAQ:MORF) Stock Rating Reaffirmed by BMO Capital Markets

Morphic (NASDAQ:MORF)‘s stock had its “buy” rating restated by research analysts at BMO Capital Markets in a note issued to investors on Sunday, AnalystRatings.com reports. MORF has been the subject of several other... 
Houghton Mifflin Harcourt (NASDAQ:HMHC) Rating Reiterated by BMO Capital Markets

Houghton Mifflin Harcourt (NASDAQ:HMHC) Rating Reiterated by BMO Capital Markets

Houghton Mifflin Harcourt (NASDAQ:HMHC)‘s stock had its “hold” rating restated by BMO Capital Markets in a research note issued to investors on Sunday, AnalystRatings.com reports. They currently have a $3.00 price... 
William Blair Begins Coverage on Vroom (NYSE:VRM)

William Blair Begins Coverage on Vroom (NYSE:VRM)

Research analysts at William Blair began coverage on shares of Vroom (NYSE:VRM) in a research note issued to investors on Sunday, The Fly reports. The firm set an “outperform” rating on the stock. Separately, Benchmark... 
Capri (NYSE:CPRI) Earns “Hold” Rating from Oppenheimer

Capri (NYSE:CPRI) Earns “Hold” Rating from Oppenheimer

Oppenheimer reissued their hold rating on shares of Capri (NYSE:CPRI) in a report released on Thursday morning, AnalystRatings.com reports. A number of other equities analysts have also issued reports on the stock. MKM Partners reduced... 
Tronox (NYSE:TROX) Downgraded to Hold at Zacks Investment Research

Tronox (NYSE:TROX) Downgraded to Hold at Zacks Investment Research

Zacks Investment Research downgraded shares of Tronox (NYSE:TROX) from a buy rating to a hold rating in a report published on Saturday morning, Zacks.com reports. According to Zacks, “Tronox Holdings plc is a vertically integrated... 
Lincoln National (NYSE:LNC) Raised to Sell at ValuEngine

Lincoln National (NYSE:LNC) Raised to Sell at ValuEngine

ValuEngine upgraded shares of Lincoln National (NYSE:LNC) from a strong sell rating to a sell rating in a research note published on Thursday morning, ValuEngine reports. Other equities analysts have also recently issued research reports... 
Morgan Stanley Boosts Kimco Realty (NYSE:KIM) Price Target to $11.00

Morgan Stanley Boosts Kimco Realty (NYSE:KIM) Price Target to $11.00

Kimco Realty (NYSE:KIM) had its price objective raised by Morgan Stanley from $7.50 to $11.00 in a research report report published on Thursday, BenzingaRatingsTable reports. The firm currently has an equal weight rating on the real... 
Tribune Publishing (NASDAQ:TPCO) Downgraded by Zacks Investment Research

Tribune Publishing (NASDAQ:TPCO) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Tribune Publishing (NASDAQ:TPCO) from a hold rating to a sell rating in a research note released on Saturday morning, Zacks.com reports. According to Zacks, “Tribune Publishing Company... 
Deutsche Bank Boosts Capri (NYSE:CPRI) Price Target to $25.00

Deutsche Bank Boosts Capri (NYSE:CPRI) Price Target to $25.00

Capri (NYSE:CPRI) had its price target upped by Deutsche Bank from $21.00 to $25.00 in a research report released on Thursday, The Fly reports. They currently have a hold rating on the stock. A number of other brokerages have also... 
Trevi Therapeutics (NASDAQ:TRVI) Downgraded by Zacks Investment Research

Trevi Therapeutics (NASDAQ:TRVI) Downgraded by Zacks Investment Research

Zacks Investment Research lowered shares of Trevi Therapeutics (NASDAQ:TRVI) from a hold rating to a sell rating in a report published on Saturday morning, Zacks.com reports. According to Zacks, “Trevi Therapeutics Inc. is a... 
General Mills (NYSE:GIS) Given New $66.00 Price Target at BMO Capital Markets

General Mills (NYSE:GIS) Given New $66.00 Price Target at BMO Capital Markets

General Mills (NYSE:GIS) had its target price lifted by BMO Capital Markets from $63.00 to $66.00 in a research report report published on Thursday, The Fly reports. The firm currently has a market perform rating on the stock. A number... 
Renewable Energy Group (NASDAQ:REGI) Downgraded by Zacks Investment Research to Hold

Renewable Energy Group (NASDAQ:REGI) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research cut shares of Renewable Energy Group (NASDAQ:REGI) from a buy rating to a hold rating in a research note published on Saturday morning, Zacks.com reports. According to Zacks, “Renewable Energy Group,... 
PLx Pharma (NASDAQ:PLXP) Downgraded by Zacks Investment Research to “Sell”

PLx Pharma (NASDAQ:PLXP) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research downgraded shares of PLx Pharma (NASDAQ:PLXP) from a hold rating to a sell rating in a research report released on Saturday morning, Zacks.com reports. According to Zacks, “PLx Pharma Inc. is a specialty... 
Neoleukin Therapeutics (NASDAQ:NLTX) Upgraded to “Buy” at Zacks Investment Research

Neoleukin Therapeutics (NASDAQ:NLTX) Upgraded to “Buy” at Zacks Investment Research

Zacks Investment Research upgraded shares of Neoleukin Therapeutics (NASDAQ:NLTX) from a hold rating to a buy rating in a report issued on Saturday, Zacks.com reports. They currently have $19.00 price objective on the stock. According... 
MEI Pharma (NASDAQ:MEIP) Earns “Buy” Rating from Ci Capital

MEI Pharma (NASDAQ:MEIP) Earns “Buy” Rating from Ci Capital

MEI Pharma (NASDAQ:MEIP)‘s stock had its “buy” rating reaffirmed by equities research analysts at Ci Capital in a report released on Sunday, AnalystRatings.com reports. They presently have a $9.00 price objective... 
Mercantile Bank (NASDAQ:MBWM) Lowered to “Hold” at Zacks Investment Research

Mercantile Bank (NASDAQ:MBWM) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research downgraded shares of Mercantile Bank (NASDAQ:MBWM) from a strong-buy rating to a hold rating in a report published on Saturday morning, Zacks.com reports. According to Zacks, “Mercantile Bank Corporation... 
QTS Realty Trust (NYSE:QTS) Lowered to “Sell” at Zacks Investment Research

QTS Realty Trust (NYSE:QTS) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of QTS Realty Trust (NYSE:QTS) from a hold rating to a sell rating in a research note released on Saturday morning, Zacks.com reports. According to Zacks, “QTS Realty Trust Inc. is a... 
MONOTARO CO LTD/ADR (OTCMKTS:MONOY) Downgraded by Zacks Investment Research

MONOTARO CO LTD/ADR (OTCMKTS:MONOY) Downgraded by Zacks Investment Research

Zacks Investment Research cut shares of MONOTARO CO LTD/ADR (OTCMKTS:MONOY) from a hold rating to a sell rating in a research note released on Saturday morning, Zacks.com reports. According to Zacks, “Monotaro Co. provides consumable... 
Midland States Bancorp (NASDAQ:MSBI) Raised to Hold at Zacks Investment Research

Midland States Bancorp (NASDAQ:MSBI) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Midland States Bancorp (NASDAQ:MSBI) from a strong sell rating to a hold rating in a research report report published on Thursday morning, Zacks.com reports. According to Zacks, “Midland... 
First Western Financial (NASDAQ:MYFW) Stock Rating Lowered by ValuEngine

First Western Financial (NASDAQ:MYFW) Stock Rating Lowered by ValuEngine

ValuEngine cut shares of First Western Financial (NASDAQ:MYFW) from a sell rating to a strong sell rating in a research note released on Thursday, ValuEngine reports. A number of other research firms also recently issued reports on... 
ValuEngine Downgrades NetEase (NASDAQ:NTES) to Sell

ValuEngine Downgrades NetEase (NASDAQ:NTES) to Sell

ValuEngine lowered shares of NetEase (NASDAQ:NTES) from a hold rating to a sell rating in a research note released on Thursday, ValuEngine reports. A number of other brokerages have also issued reports on NTES. Nomura reaffirmed a... 
Tristate Capital (NASDAQ:TSC) Upgraded to Hold by Zacks Investment Research

Tristate Capital (NASDAQ:TSC) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of Tristate Capital (NASDAQ:TSC) from a sell rating to a hold rating in a research report sent to investors on Saturday morning, Zacks.com reports. According to Zacks, “Tristate Capital... 
Rockwell Medical (NASDAQ:RMTI) Upgraded to Hold by Zacks Investment Research

Rockwell Medical (NASDAQ:RMTI) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a sell rating to a hold rating in a research report report published on Saturday, Zacks.com reports. According to Zacks, “Rockwell Medical Technologies,... 
SS&C Technologies (NASDAQ:SSNC) Upgraded by Zacks Investment Research to “Hold”

SS&C Technologies (NASDAQ:SSNC) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of SS&C Technologies (NASDAQ:SSNC) from a sell rating to a hold rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “SS&C Technologies... 
Qutoutiao (NASDAQ:QTT) Upgraded to “Hold” by Zacks Investment Research

Qutoutiao (NASDAQ:QTT) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Qutoutiao (NASDAQ:QTT) from a sell rating to a hold rating in a report released on Saturday morning, Zacks.com reports. According to Zacks, “Qutoutiao Inc. is a mobile content aggregator... 
IMPINJ (NASDAQ:PI) Downgraded to “Hold” at Zacks Investment Research

IMPINJ (NASDAQ:PI) Downgraded to “Hold” at Zacks Investment Research

Zacks Investment Research downgraded shares of IMPINJ (NASDAQ:PI) from a buy rating to a hold rating in a research note published on Saturday, Zacks.com reports. According to Zacks, “Impinj, Inc. is a provider of referral and... 
Nicolet Bankshares (NASDAQ:NCBS) Upgraded by Zacks Investment Research to “Hold”

Nicolet Bankshares (NASDAQ:NCBS) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of Nicolet Bankshares (NASDAQ:NCBS) from a sell rating to a hold rating in a research note published on Saturday morning, Zacks.com reports. According to Zacks, “Nicolet Bankshares Inc.... 
Neos Therapeutics (NASDAQ:NEOS) Downgraded to Sell at Zacks Investment Research

Neos Therapeutics (NASDAQ:NEOS) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of Neos Therapeutics (NASDAQ:NEOS) from a hold rating to a sell rating in a research report report published on Saturday morning, Zacks.com reports. According to Zacks, “Neos Therapeutics,... 
Passage Bio (NASDAQ:ZNTL) Stock Rating Lowered by Zacks Investment Research

Passage Bio (NASDAQ:ZNTL) Stock Rating Lowered by Zacks Investment Research

Zacks Investment Research downgraded shares of Passage Bio (NASDAQ:ZNTL) from a hold rating to a sell rating in a research note published on Saturday, Zacks.com reports. According to Zacks, “Zentalis Pharmaceuticals, Inc. is... 
Zosano Pharma (NASDAQ:ZSAN) Upgraded by Zacks Investment Research to “Hold”

Zosano Pharma (NASDAQ:ZSAN) Upgraded by Zacks Investment Research to “Hold”

Zacks Investment Research upgraded shares of Zosano Pharma (NASDAQ:ZSAN) from a sell rating to a hold rating in a report published on Saturday morning, Zacks.com reports. According to Zacks, “Zosano Pharma Corporation is a biopharmaceutical... 
Yield10 Bioscience (NASDAQ:YTEN) Rating Increased to Hold at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN) Rating Increased to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of Yield10 Bioscience (NASDAQ:YTEN) from a sell rating to a hold rating in a report issued on Saturday morning, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an... 
Zagg (NASDAQ:ZAGG) Downgraded to “Sell” at Zacks Investment Research

Zagg (NASDAQ:ZAGG) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Zagg (NASDAQ:ZAGG) from a hold rating to a sell rating in a research note issued to investors on Saturday morning, Zacks.com reports. According to Zacks, “ZAGG Inc. designs, manufactures... 
XPEL (NASDAQ:XPEL) Downgraded by Zacks Investment Research to Sell

XPEL (NASDAQ:XPEL) Downgraded by Zacks Investment Research to Sell

Zacks Investment Research cut shares of XPEL (NASDAQ:XPEL) from a hold rating to a sell rating in a report released on Saturday morning, Zacks.com reports. According to Zacks, “XPEL Inc. is a provider of protective films and... 
Xilinx (NASDAQ:XLNX) Upgraded to Buy by Zacks Investment Research

Xilinx (NASDAQ:XLNX) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Xilinx (NASDAQ:XLNX) from a hold rating to a buy rating in a research note published on Saturday, Zacks.com reports. The firm currently has $98.00 price target on the programmable devices... 
WesBanco (NASDAQ:WSBC) Upgraded at Zacks Investment Research

WesBanco (NASDAQ:WSBC) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of WesBanco (NASDAQ:WSBC) from a strong sell rating to a hold rating in a research report released on Saturday morning, Zacks.com reports. According to Zacks, “WESBANCO, INC. is a multi-bank... 
Werner Enterprises (NASDAQ:WERN) Upgraded to “Buy” by Zacks Investment Research

Werner Enterprises (NASDAQ:WERN) Upgraded to “Buy” by Zacks Investment Research

Zacks Investment Research upgraded shares of Werner Enterprises (NASDAQ:WERN) from a hold rating to a buy rating in a research note released on Saturday morning, Zacks.com reports. Zacks Investment Research currently has $46.00 price... 
Western Digital (NASDAQ:WDC) Lowered to Strong Sell at Zacks Investment Research

Western Digital (NASDAQ:WDC) Lowered to Strong Sell at Zacks Investment Research

Zacks Investment Research lowered shares of Western Digital (NASDAQ:WDC) from a hold rating to a strong sell rating in a report published on Saturday, Zacks.com reports. The firm currently has $46.00 target price on the data storage... 
Zacks Investment Research Lowers Washington Trust Bancorp (NASDAQ:WASH) to Sell

Zacks Investment Research Lowers Washington Trust Bancorp (NASDAQ:WASH) to Sell

Zacks Investment Research downgraded shares of Washington Trust Bancorp (NASDAQ:WASH) from a hold rating to a sell rating in a research report report published on Saturday, Zacks.com reports. According to Zacks, “Washington... 
Veritex (NASDAQ:VBTX) Upgraded to “Hold” by Zacks Investment Research

Veritex (NASDAQ:VBTX) Upgraded to “Hold” by Zacks Investment Research

Zacks Investment Research upgraded shares of Veritex (NASDAQ:VBTX) from a sell rating to a hold rating in a report issued on Saturday morning, Zacks.com reports. According to Zacks, “Veritex Holdings, Inc. is a bank holding... 
Usio (NASDAQ:USIO) Lowered to “Sell” at Zacks Investment Research

Usio (NASDAQ:USIO) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research downgraded shares of Usio (NASDAQ:USIO) from a hold rating to a sell rating in a research report released on Saturday morning, Zacks.com reports. According to Zacks, “Usio Inc. provides integrated payment... 
Net 1 UEPS Technologies (NASDAQ:UEPS) Raised to Buy at Zacks Investment Research

Net 1 UEPS Technologies (NASDAQ:UEPS) Raised to Buy at Zacks Investment Research

Zacks Investment Research upgraded shares of Net 1 UEPS Technologies (NASDAQ:UEPS) from a hold rating to a buy rating in a research report report published on Saturday, Zacks.com reports. They currently have $3.50 price target on the... 
VERONA PHARMA P/S (NASDAQ:VRNA) Upgraded by Zacks Investment Research to Buy

VERONA PHARMA P/S (NASDAQ:VRNA) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of VERONA PHARMA P/S (NASDAQ:VRNA) from a hold rating to a buy rating in a research note issued to investors on Saturday, Zacks.com reports. They currently have $5.25 price objective on the... 
Twin Disc (NASDAQ:TWIN) Upgraded to Hold by Zacks Investment Research

Twin Disc (NASDAQ:TWIN) Upgraded to Hold by Zacks Investment Research

Zacks Investment Research upgraded shares of Twin Disc (NASDAQ:TWIN) from a strong sell rating to a hold rating in a report released on Saturday morning, Zacks.com reports. According to Zacks, “TWIN DISC, INC. designs, manufactures... 
Verrica Pharmaceuticals (NASDAQ:VRCA) Upgraded at Zacks Investment Research

Verrica Pharmaceuticals (NASDAQ:VRCA) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Verrica Pharmaceuticals (NASDAQ:VRCA) from a sell rating to a hold rating in a research note issued to investors on Saturday morning, Zacks.com reports. According to Zacks, “Verrica... 
vTv Therapeutics (NASDAQ:VTVT) Downgraded to Sell at Zacks Investment Research

vTv Therapeutics (NASDAQ:VTVT) Downgraded to Sell at Zacks Investment Research

Zacks Investment Research lowered shares of vTv Therapeutics (NASDAQ:VTVT) from a hold rating to a sell rating in a research report sent to investors on Saturday morning, Zacks.com reports. According to Zacks, “vTv Therapeutics... 
New Home (NYSE:NWHM) Lifted to Sell at ValuEngine

New Home (NYSE:NWHM) Lifted to Sell at ValuEngine

ValuEngine upgraded shares of New Home (NYSE:NWHM) from a strong sell rating to a sell rating in a report issued on Thursday morning, ValuEngine reports. Shares of NWHM opened at $3.20 on Thursday. The firm has a market capitalization... 
Zacks Investment Research Lowers Trinseo (NYSE:TSE) to Sell

Zacks Investment Research Lowers Trinseo (NYSE:TSE) to Sell

Zacks Investment Research lowered shares of Trinseo (NYSE:TSE) from a hold rating to a sell rating in a research report report published on Saturday, Zacks.com reports. According to Zacks, “Trinseo S.A. is a global materials... 
Unilever (NYSE:UL) Downgraded by Zacks Investment Research to “Sell”

Unilever (NYSE:UL) Downgraded by Zacks Investment Research to “Sell”

Zacks Investment Research lowered shares of Unilever (NYSE:UL) from a hold rating to a sell rating in a report issued on Saturday morning, Zacks.com reports. According to Zacks, “Unilever plc is engaged in manufacturing of branded...